Naoko Takeuchi

1.2k total citations
57 papers, 764 citations indexed

About

Naoko Takeuchi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Naoko Takeuchi has authored 57 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Naoko Takeuchi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Medical Imaging and Pathology Studies (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Naoko Takeuchi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Medical Imaging and Pathology Studies (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Naoko Takeuchi collaborates with scholars based in Japan, Australia and United States. Naoko Takeuchi's co-authors include Yumi Sugimoto, Ikuko Kimura, Jun Yamada, Kazuyoshi Horisaka, Naoki Omachi, Shinji Atagi, Kyoichi Okishio, J. Nevil Amos, Paul Sunnucks and Alexandra Pavlova and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Ecology.

In The Last Decade

Naoko Takeuchi

53 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoko Takeuchi Japan 16 284 196 132 109 93 57 764
M. Thomson Australia 23 317 1.1× 176 0.9× 267 2.0× 443 4.1× 205 2.2× 75 1.4k
Tingting Huang China 19 80 0.3× 113 0.6× 521 3.9× 86 0.8× 45 0.5× 81 1.1k
Enrique Moreno Spain 27 163 0.6× 147 0.8× 212 1.6× 590 5.4× 452 4.9× 58 1.7k
R Enríquez Spain 13 82 0.3× 37 0.2× 184 1.4× 74 0.7× 80 0.9× 53 1.3k
Emanuele Ferri Italy 15 99 0.3× 67 0.3× 185 1.4× 183 1.7× 26 0.3× 46 720
Katie Lee Australia 11 183 0.6× 64 0.3× 140 1.1× 137 1.3× 65 0.7× 34 650
Mina Ahloulay France 13 303 1.1× 93 0.5× 332 2.5× 98 0.9× 111 1.2× 15 901
Paolo Emilio Manconi Italy 19 62 0.2× 56 0.3× 152 1.2× 67 0.6× 182 2.0× 57 1.0k
D. Fuchs Austria 18 72 0.3× 161 0.8× 229 1.7× 51 0.5× 177 1.9× 57 979
Paul D. Light United States 14 77 0.3× 56 0.3× 52 0.4× 39 0.4× 43 0.5× 26 871

Countries citing papers authored by Naoko Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Naoko Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Takeuchi more than expected).

Fields of papers citing papers by Naoko Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Takeuchi. The network helps show where Naoko Takeuchi may publish in the future.

Co-authorship network of co-authors of Naoko Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Takeuchi. A scholar is included among the top collaborators of Naoko Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Takeuchi. Naoko Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arai, Toru, Takayuki Takimoto, Naoko Takeuchi, et al.. (2024). Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study. Respiratory Investigation. 62(6). 1161–1167. 1 indexed citations
2.
Inoue, Tomohiro, Kazuhiro Ohwaki, Naoko Takeuchi, et al.. (2024). Influence of an improvement in frontal lobe hemodynamics on neurocognitive function in adult patients with moyamoya disease. Neurosurgical Review. 47(1). 395–395. 1 indexed citations
3.
Sumikawa, Hiromitsu, et al.. (2024). Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease. Respiratory Investigation. 62(5). 872–878.
4.
Arai, Toru, Hiromitsu Sumikawa, Takayuki Takimoto, et al.. (2023). Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis. Oncology. 101(5). 303–312. 4 indexed citations
5.
Arai, Toru, et al.. (2023). Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 12(23). 7446–7446. 2 indexed citations
6.
Takeuchi, Naoko & Saiko Kurosawa. (2023). 2069P QoL changes of caregivers during first-line palliative chemotherapy for patients with incurable cancer. Annals of Oncology. 34. S1090–S1091. 1 indexed citations
7.
Inagaki, Yuji, Toru Arai, Naoko Takeuchi, et al.. (2023). Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome. Internal Medicine. 63(10). 1451–1457. 1 indexed citations
8.
9.
Takeuchi, Naoko, Toru Arai, Yumiko Sasaki, et al.. (2022). Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia. Journal of Thoracic Disease. 14(11). 4352–4360. 3 indexed citations
10.
Hirose, Masaki, Toru Arai, Chikatoshi Sugimoto, et al.. (2021). B cell‐activating factors in autoimmune pulmonary alveolar proteinosis. Orphanet Journal of Rare Diseases. 16(1). 115–115. 4 indexed citations
11.
Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2017). OA08.05 Efficacy and Cerebrospinal Fluid Concentration of Afatinib in NSCLC Patients with EGFR Mutation Developing Leptomeningeal Carcinomatosis. Journal of Thoracic Oncology. 12(1). S273–S273. 6 indexed citations
12.
Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2016). Afatinib efficacy and cerebrospinal fluid concentration in NSCLC patients with EGFR mutation developing leptomeningeal carcinomatosis. Annals of Oncology. 27. vi428–vi428. 6 indexed citations
13.
Arai, Toru, Yoshikazu Inoue, Chikatoshi Sugimoto, et al.. (2013). CYFRA 21‐1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis. Respirology. 19(2). 246–252. 29 indexed citations
14.
Kakizawa, Hideaki, Naoko Takeuchi, Naoyuki Toyota, et al.. (2011). Cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma via the internal mammary artery: how to avoid this complication. Japanese Journal of Radiology. 29(5). 307–315. 2 indexed citations
15.
Takeuchi, Naoko & Sachiyo Murashima. (2008). Relationships between Characteristics, Beliefs, and Self-care in Hemodialysis Patients. Journal of Japan Academy of Nursing Science. 28(4). 37–45. 1 indexed citations
16.
Ogawa, Asao, Ichiro Mizuta, Naoko Takeuchi, et al.. (2004). Electrogastrography abnormality in eating disorders. Psychiatry and Clinical Neurosciences. 58(3). 300–310. 24 indexed citations
17.
Takeuchi, Naoko, Takahiko Kawamura, Nobuhisa Nakamura, et al.. (2002). The effect of cigarette smoking on soluble adhesion molecules in middle‐aged patients with Type 2 diabetes mellitus. Diabetic Medicine. 19(1). 57–64. 25 indexed citations
18.
Yamada, Jun, et al.. (1993). Peripherally administered serotonin induces hyperglucagonemia in mice. Life Sciences. 52(23). 1845–1849. 3 indexed citations
19.
Yamada, Jun, Yumi Sugimoto, Ikuko Kimura, et al.. (1992). Hyperglucagonemia induced in mice by tryptamine: Involvement of the peripheral 5-HT2 receptors. European Journal of Pharmacology. 216(2). 307–310. 2 indexed citations
20.
Sugimoto, Yumi, et al.. (1990). Effects of Serotonin on Blood Glucose and Insulin Levels of Glucose- and Streptozotocin-Treated Mice. The Japanese Journal of Pharmacology. 54(1). 93–96. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Thomson Breakdown of academic impact, for papers by Tingting Huang Breakdown of academic impact, for papers by Enrique Moreno Breakdown of academic impact, for papers by R Enríquez Breakdown of academic impact, for papers by Emanuele Ferri Breakdown of academic impact, for papers by Katie Lee Breakdown of academic impact, for papers by Mina Ahloulay Breakdown of academic impact, for papers by Paolo Emilio Manconi Breakdown of academic impact, for papers by D. Fuchs Breakdown of academic impact, for papers by Paul D. Light
Rankless by CCL
2026